Organization

Sismanoglio Hospital, Athens, Greece

2 abstracts

Abstract
ADALIMUMAB IS EFFECTIVE AND WELL-TOLERATED IN TREATING ANKYLOSING SPONDYLITIS (AS) IN REAL-LIFE CLINICAL PRACTICE: PRELIMINARY RESULTS OF THE RHAPSODY TRIAL
Org: Rheumatology, Society of Patients with Rheumatism, Cracow, Poland, Charité University Hospital, Berlin Heals, Germany, CHU de Henri-Mondor,
Abstract
ADALIMUMAB (HUMIRA®) THERAPY IMPROVES INFLAMMATORY BOWEL DISEASE (IBD) AND PSORIASIS (PS) IN PATIENTS WITH ANKYLOSING SPONDYLITIS (AS)
Org: Rheumazentrum Ruhrgebiet, Herne, Germany, Ospedale San Carlo di Potenza, Córdoba, Spain, Sismanoglio Hospital, Athens, Greece, Abbott GmbH & Co KG, Ludwigshafen, Germany, Charité – University Medicine Berlin, Berlin, Germany,